While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
Palm Beach, FL – November 16, 2022 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has devastated the world and impacted millions of people… as a result, the demand for the creation of therapeutic treatments has increased due to the pandemic outbreak. The pandemic outbreak has surged the need for the development of therapeutic solutions […]
Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print
Complete elimination of viral load in 100% of patients at day 7 vs 6% in placebo (p=.001) Complete elimination of viral load in 88% of patients at day 3 vs 0% in placebo (p=.001) Treated population experienced no viral rebounds within the 14-day observation period Boston, MA – November 16, 2022 – BIOXYTRAN, INC. […]
